Analyst Ratings for Capricor Therapeutics (CAPR)
CAPR Rating Summary
CAPR Price Target Summary
- Highest: $62.00 (Cantor Fitzgerald)
- Lowest: $12.00 (Roth/MKM)
- Average: $44.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.25 (+58.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$44.25 (+58.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/30/2025 | Alliance Global Partners | Matt Venezia | New Coverage | Buy (N/A) |
20.00 (N/A) |
11.15 (27.90) |
150.22% | Details |
| 6/26/2025 | B.Riley » Updated 12/15/2025 |
Madison El-Saadi | New Coverage | Buy (N/A) |
50.00 (21.00) |
9.25 (27.90) |
201.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
